Intravenous immunoglobulin products contain neutralizing antibodies to vaccinia.
about
Biological activity of an intravenous preparation of human vaccinia immune globulin in mouse models of vaccinia virus infection.Combination therapy of vaccinia virus infection with human anti-H3 and anti-B5 monoclonal antibodies in a small animal model.Protection of rabbits and immunodeficient mice against lethal poxvirus infections by human monoclonal antibodies.Vaccinia virus extracellular enveloped virion neutralization in vitro and protection in vivo depend on complementApplication of bioluminescence imaging to the prediction of lethality in vaccinia virus-infected mice.
P2860
Intravenous immunoglobulin products contain neutralizing antibodies to vaccinia.
description
2004 nî lūn-bûn
@nan
2004 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Intravenous immunoglobulin products contain neutralizing antibodies to vaccinia.
@ast
Intravenous immunoglobulin products contain neutralizing antibodies to vaccinia.
@en
type
label
Intravenous immunoglobulin products contain neutralizing antibodies to vaccinia.
@ast
Intravenous immunoglobulin products contain neutralizing antibodies to vaccinia.
@en
prefLabel
Intravenous immunoglobulin products contain neutralizing antibodies to vaccinia.
@ast
Intravenous immunoglobulin products contain neutralizing antibodies to vaccinia.
@en
P2093
P2860
P1433
P1476
Intravenous immunoglobulin products contain neutralizing antibodies to vaccinia.
@en
P2093
Goldsmith JC
Manischewitz J
Mikolajczyk M
P2860
P304
P356
10.1111/J.0042-9007.2004.00397.X
P577
2004-02-01T00:00:00Z